Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

BACKGROUND: Diabetes is a prognostic factor for some malignancies, but its association with outcome in patients with advanced or metastatic colorectal cancer (CRC) is less clear. METHODS: This cohort study was nested within a randomized trial of first-line chemotherapy and bevacizumab and/or cetuxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Justin C, Zhang, Sui, Ou, Fang-Shu, Venook, Alan P, Niedzwiecki, Donna, Lenz, Heinz-Josef, Innocenti, Federico, O’Neil, Bert H, Shaw, James E, Polite, Blase N, Denlinger, Crystal S, Atkins, James N, Goldberg, Richard M, Ng, Kimmie, Mayer, Robert J, Blanke, Charles D, O’Reilly, Eileen M, Fuchs, Charles S, Meyerhardt, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043296/
https://www.ncbi.nlm.nih.gov/pubmed/32259016
http://dx.doi.org/10.1093/jncics/pkz078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043296/
https://www.ncbi.nlm.nih.gov/pubmed/32259016
http://dx.doi.org/10.1093/jncics/pkz078

Ejemplares similares